Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride can cause itching, burning, and other side effects that may not go away after treatment.

Finasteride discontinuation increases sperm count in men.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

Saw palmetto is effective for men's prostate issues, may help women with certain conditions, and could potentially treat hair loss, but should be used carefully due to possible side effects and interactions.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Finasteride may cause gum side effects in some patients.

The editorial discusses the effectiveness and safety of various laser and energy-based cosmetic treatments.

Dutasteride use can lead to a stable decline in sexual function that is not affected by age or prostate size.

A biodegradable system can deliver finasteride consistently, reducing the need for daily pills.

The document concludes that hair loss in women is complex, often linked to aging, health conditions, and nutritional deficiencies, and emotional impacts should not be underestimated.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Finasteride for hair loss in young men increases the risk of sexual dysfunction.

Developing plant-based treatments for alopecia is promising and necessary.

Finasteride may affect brain chemistry and behavior, offering potential for treating certain mental health conditions.

Topical minoxidil may slow hair loss but often doesn't lead to satisfactory hair regrowth and requires ongoing treatment.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

Finasteride and dutasteride can harm male reproductive health, affecting sperm and causing sexual dysfunction.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

The document emphasizes the need for surgeons to stay updated with the latest hair restoration and removal techniques and introduces new, essential information in the field.

Cyproterone slightly inhibited hair growth in castrated mice, while tamoxifen significantly inhibited hair growth in castrated mice but not in normal mice.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Microneedles are becoming essential tools in medicine for sensing, drug delivery, and communication.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Topical tretinoin may increase beard hair density.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

Hair is culturally and economically valuable, and its weight is now used to measure the effectiveness of hair growth treatments.

The book is a comprehensive resource on hair disorders, but lacks information on some conditions.